Novel Technologies for the Treatment of Inflammatory Bowel Diseases

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. The company currently seeks to engage with academic partners having or developing a technology solution that can be used in the diagnosis or treatment of inflammatory bowel diseases. Solutions that target all complications due to Crohn’s disease and Colitis specifically are of high interest. 

Solutions should meet the specifications below: 

• Stage of Development: Initial prototype/proof of concept through to clinical testing (or beyond)
• Delivery methods:
  • Endoscopic delivery, but other minimally invasive solutions will also be of interest
  • External technologies, e.g. wearable, self‑diagnostics, symptom‑tracking apps 
• Focused devices/concepts preferred, but combination devices/concepts will also be of interest
• Outside of scope: Surgical, laparoscopy and pharmaceutical solutions

Further areas of interest: 

• Technologies which can be adapted to combine with an endoscopic system
• Devices composed of bio-degradable materials, e.g. stents
• Drug delivery systems that can be adapted for localised delivery of technology
• Robotics and AI to assist in the delivery of endoscopic treatment 

Boston Scientific are open to collaboration with a team behind a technology, acquisition of a research program, collaborative projects, and technology licensing. If appropriate, please include in your submission future development milestones. 

The submission from can be downloaded here.